A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndrome.
Campbell K, Neul JL, Lieberman DN, Berry-Kravis E, Benke TA, Fu C, Percy A, Suter B, Morris D, Carpenter RL, Marsh ED, von Hehn J.
Campbell K, et al. Among authors: fu c.
J Neurodev Disord. 2025 Jan 24;17(1):4. doi: 10.1186/s11689-025-09591-y.
J Neurodev Disord. 2025.
PMID: 39856538
Clinical Trial.